Regel Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
238 Main St, Cambridge, Massachusetts, 0...Website
www.regeltherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Regel Therapeutics
Regel Therapeutics is focused on developing innovative therapeutic solutions for severe genetic diseases using its proprietary Targeted EpiEditing platform. This technology aims to correct abnormal gene expression specifically in affected cells without altering the genome, addressing significant unmet medical needs. The company is advancing its lead programs for Dravet Syndrome and SCN2A Haploinsufficiency towards clinical application. Regel Therapeutics targets patients suffering from these conditions across the US and Europe.Explore more
Regel Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Regel Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Regel Therapeutics
Earning: See what the market has to say on Regel Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Regel Therapeutics launches new products
Click to see if Regel Therapeutics had a recent Job posting/layoffs
Check if Regel Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Regel Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Regel Therapeutics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Regel Therapeutics has new funding data
Recommended Actions
Find VP level buyers at Regel Therapeutics
Find 2 more new buyers
Compare Similar Companies to Regel Therapeutics
Compare insights from companies similar to Regel Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Regel Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Regel Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Regel Therapeutics.
Regel Therapeutics Tech Stack
A closer look at the technologies used by Regel Therapeutics
See more technologies
Regel Therapeutics News & Media
Regel Therapeutics Appoints Stephen J. Farr as New Chief Executive Officer
CAMBRIDGE, Mass. and BERKELEY, Calif., June 20, 2024 /PRNewswire/ -- The Board of Directors of Regel Therapeutics, a gene regulation company, announced that Stephen J. Farr, PhD, begins today as Chief Executive Officer (CEO). Dr. Farr served as President and CEO of Zogenix from 2015 until...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Regel Therapeutics
Sign Up For FreeTo access detailed company insights
Regel Therapeutics is focused on developing innovative therapeutic solutions for severe genetic diseases using its proprietary Targeted EpiEditing platform. This technology aims to correct abnormal gene expression specifically in affected cells without altering the genome, addressing significant unmet medical needs. The company is advancing its lea... Read More
